Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline

Fundam Clin Pharmacol. 1992;6(6):247-9. doi: 10.1111/j.1472-8206.1992.tb00117.x.

Abstract

The effects of 3 phosphodiesterase (PDE) inhibitors, rolipram (PDE IV), milrinone (PDE III) and theophylline (non-selective) on PAF (50 ng kg-1; iv)-induced airway vascular leakage have been evaluated in guinea-pigs. Rolipram (3-300 micrograms kg-1; iv) reduced the increase in permeability induced by PAF at all airway levels whereas milrinone (10-1000 micrograms kg-1; iv) and theophylline (30 mg kg-1; iv) were without effects. The anti-leakage activity of rolipram may be of therapeutic value in asthma.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillary Permeability / drug effects*
  • Evans Blue
  • Guinea Pigs
  • Milrinone
  • Phosphodiesterase Inhibitors / pharmacology*
  • Platelet Activating Factor / antagonists & inhibitors*
  • Pyridones / pharmacology
  • Pyrrolidinones / pharmacology
  • Respiratory System / blood supply
  • Respiratory System / drug effects*
  • Rolipram
  • Theophylline / pharmacology

Substances

  • Phosphodiesterase Inhibitors
  • Platelet Activating Factor
  • Pyridones
  • Pyrrolidinones
  • Evans Blue
  • Theophylline
  • Milrinone
  • Rolipram